NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Tata Elxsi (TELX) Research Report

Company Overview

Tata Elxsi (TELX) is a leading provider of IT ER&D (engineering, research and development) services with capabilities across Automotive, Broadcast & Communications, and Healthcare industries.

Financial Performance

Read also: SMR Jewels IPO Successfully Lists with Institutional Support

Tata Elxsi's 9MFY26 revenue declined by 2% YoY, with a sequential recovery of 3.9% led by a 7.7% rebound in Transportation driven by SDV-driven OEM ramp-ups and normalization of key client engagements. However, most geographies posted YoY declines, with Europe and North America showing sequential recovery of 5% and 13% respectively, while India fell 9% due to weaker automotive supplier demand.

EBITDA Margin

The company's EBITDA margin declined by 534 bps YoY to 22% in 9MFY26, but expanded by 220 bps QoQ due to 200 bps utilization-led operating leverage, 80-85 bps cost discipline, and 35 bps forex gains, partly offset by a 110 bps wage hike impact.

Outlook

Read also: Zepto Nears $1 Billion Quarterly Net Order Value Milestone Before IPO

Tata Elxsi's domain expertise, design-led approach, and offshore execution position it for steady recovery. We expect anchor client recovery over the next 1-2 quarters and recommend a Buy rating with a target price of Rs.5,135 at current market price (CMP).

Valuation

We value TELX at 33x FY28E EPS.

Recommendation

  • Rating: Buy
  • Target Price: Rs.5,135
  • Current Market Price: CMP

Investor Takeaway

Investors should consider Tata Elxsi for its potential growth in the IT ER&D services sector.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.